Clinical Trials Directory

Trials / Completed

CompletedNCT00683774

Insulin and Polycystic Ovary Syndrome

Determination if Direct Inhibition of Insulin Release With Diazoxide Decreases Renal Clearance of D-Chiroinositol (DCI) and Increases Circulating DCI in Obese Women With Polycystic Ovary Syndrome (PCOS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Increased insulin levels leads to increased secretion of D-chiro inositol(DCI) from the kidneys in women with PCOS, but not in normal women. This leads to a reduction in circulating DCI and insulin stimulated release of DCI-IPG.To determine if decreasing circulating insulin directly by inhibition of islet insulin release with diazoxide in obese women with PCOS 1)decreases the renal clearance of DCI and 2) increases the circulating concentration of DCI.

Conditions

Interventions

TypeNameDescription
DRUGdiazoxide100mg orally three times per day for 10 days

Timeline

Start date
2005-11-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2008-05-23
Last updated
2017-06-14
Results posted
2014-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00683774. Inclusion in this directory is not an endorsement.